Literature DB >> 31719886

Comparison of Candidate Cell Populations for the Recellularization of Decellularized Heart Valves.

Mitchell VeDepo1,2, Eric Buse1, Arghya Paul2,3, Richard Hopkins1, Gabriel Converse1.   

Abstract

INTRODUCTION: Heart valve tissue engineering may provide improved treatment for valvular heart disease, yet development of a tissue engineered heart valve (TEHV) has been limited by incomplete recellularization of the valve leaflets. In this study, we compare the leaflet recellularization potential of candidate cell populations.
METHODS: Four cell populations were tested: bone marrow mononuclear cells (MNC), 5 million bone marrow mesenchymal stem cells (MSC), 10 million bone marrow mesenchymal stem cells (MSC2), and 5 million valve interstitial cells (VIC). Candidate cell populations were seeded onto decellularized heart valves and underwent similar conditioning in a low-flow bioreactor for 2 weeks.
RESULTS: MSC2 valves demonstrated the best recellularization of the interstitial leaflet tissue as well as an appropriate cell phenotype, mechanical properties, and biochemical composition. MSC valves exhibited similar leaflet repopulation, yet had decreased mechanical and biochemical properties. MNC seeding resulted in minimal recellularization of the leaflet, though an additional time point group found cells present after 3 days, which seemed to disappear at 2 weeks. VIC seeding resulted in cell clumping on the leaflet surface and poor recellularization.
CONCLUSIONS: The results of this study suggest mesenchymal stem cells are a preferred cell population for TEHV recellularization. Additionally, MSCs demonstrate the ability for repopulation of the distal valve leaflet, which will lead to more complete recellularization of future TEHVs. © Biomedical Engineering Society 2018.

Entities:  

Keywords:  Mesenchymal stem cells; Mononuclear cells; Valve interstitial cells

Year:  2018        PMID: 31719886      PMCID: PMC6816706          DOI: 10.1007/s12195-018-0524-0

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  24 in total

Review 1.  The cardiac valve interstitial cell.

Authors:  Patricia M Taylor; Puspa Batten; Nigel J Brand; Penny S Thomas; Magdi H Yacoub
Journal:  Int J Biochem Cell Biol       Date:  2003-02       Impact factor: 5.085

2.  Design and efficacy of a single-use bioreactor for heart valve tissue engineering.

Authors:  Gabriel L Converse; Eric E Buse; Kari R Neill; Christopher R McFall; Holley N Lewis; Mitchell C VeDepo; Rachael W Quinn; Richard A Hopkins
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2015-10-15       Impact factor: 3.368

Review 3.  Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration.

Authors:  Settimio Pacelli; Sayantani Basu; Jonathan Whitlow; Aparna Chakravarti; Francisca Acosta; Arushi Varshney; Saman Modaresi; Cory Berkland; Arghya Paul
Journal:  Adv Drug Deliv Rev       Date:  2017-07-19       Impact factor: 15.470

4.  Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts.

Authors:  Hirotsugu Kurobe; Shuhei Tara; Mark W Maxfield; Kevin A Rocco; Paul S Bagi; Tai Yi; Brooks V Udelsman; Ethan W Dean; Ramak Khosravi; Heather M Powell; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2014-12-29       Impact factor: 3.056

5.  Species-specific effects of aortic valve decellularization.

Authors:  Mitchell C VeDepo; Eric E Buse; Rachael W Quinn; Todd D Williams; Michael S Detamore; Richard A Hopkins; Gabriel L Converse
Journal:  Acta Biomater       Date:  2017-01-06       Impact factor: 8.947

6.  Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.

Authors:  Jason D Roh; Rajendra Sawh-Martinez; Matthew P Brennan; Steven M Jay; Lesley Devine; Deepak A Rao; Tai Yi; Tamar L Mirensky; Ani Nalbandian; Brooks Udelsman; Narutoshi Hibino; Toshiharu Shinoka; W Mark Saltzman; Edward Snyder; Themis R Kyriakides; Jordan S Pober; Christopher K Breuer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-05       Impact factor: 11.205

7.  Phenotypic characterization of isolated valvular interstitial cell subpopulations.

Authors:  Tracy L Blevins; Joshua L Carroll; Alina M Raza; K Jane Grande-Allen
Journal:  J Heart Valve Dis       Date:  2006-11

8.  Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells.

Authors:  D A Filip; A Radu; M Simionescu
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

9.  Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

Authors:  Grazia Maria Spaggiari; Andrea Capobianco; Heba Abdelrazik; Flavio Becchetti; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Blood       Date:  2007-10-19       Impact factor: 22.113

10.  In-vivo repopularization of a tissue-engineered heart valve in a human subject.

Authors:  Pascal M Dohmen; Steffen Hauptmann; Alexander Terytze; Wolfgang F Konertz
Journal:  J Heart Valve Dis       Date:  2007-07
View more
  1 in total

Review 1.  Recellularization of Native Tissue Derived Acellular Scaffolds with Mesenchymal Stem Cells.

Authors:  Ebtehal Ahmed; Tarek Saleh; Meifeng Xu
Journal:  Cells       Date:  2021-07-15       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.